systematic_review
    2021
    High Quality

    Omega-3 fatty acids for depression: a systematic review and meta-analysis of randomised controlled trials

    Appleton KM, Sallis HM, Perry R, Ness AR, Churchill R

    Published in Cochrane Database of Systematic Reviews

    Methodology

    Cochrane review of randomised trials of omega-3 supplementation for major depressive disorder symptom severity.

    Key Findings

    Omega-3 produced a small effect on depressive symptoms of uncertain clinical importance, with low certainty evidence.

    Conclusions

    Omega-3 offers at best a modest mood benefit.

    Limitations

    Low certainty; small trial bias likely.

    Supplements Studied

    Omega-3 produced a small effect on depressive symptoms of uncertain clinical importance

    Outcomes Measured

    Seasonal Mood Support

    Omega-3 produced a small effect on depressive symptoms of uncertain clinical importance

    Related Health Concerns

    Depression

    Study Details

    Year:2021
    Sample Size:4,605
    Duration:12 weeks
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.